Publications

ZORA Publication List

Publications

• Journal Article

  • 2012

    • Obrecht, Daniel; Chevalier, Eric; Moehle, Kerstin; Robinson, John A (2012). β-Hairpin protein epitope mimetic technology in drug discovery. Drug Discovery Today: Technologies, 9(1):e63-e69.
    • Schmartz, Patrick; Wölfel, Katharina; Zerbe, Katja; Gad, Emad; El Tamany, El Sayed; Ibrahim, Hassen K; Abou-Hadeed, Khaled; Robinson, John A (2012). Substituent effects on the phenol coupling reaction catalyzed by the vancomycin biosynthetic P450 enzyme OxyB. Angewandte Chemie Internationale Edition, 51:11468-11472.

  • 2011

    • Riedel, T; Ghasparian, A; Moehle, K; Rusert, P; Trkola, A; Robinson, J A (2011). Synthetic virus-like particles and conformationally constrained peptidomimetics in vaccine design. ChemBioChem, 12(18):2829-2836.
    • Lalonde, M S; Lobritz, M A; Ratcliff, A; Chamanian, M; Athanassiou, Z; Tyagi, M; Wong, J; Robinson, J A; Karn, J; Varani, G; Arts, Eric J (2011). Inhibition of both HIV-1 reverse transcription and gene expression by a cyclic peptide that binds the Tat-transactivating response element (TAR) RNA. PLoS Pathogens, 7(5):e1002038.
    • Ghasparian, A; Riedel, T; Koomullil, J; Moehle, K; Gorba, C; Svergun, D I; Perriman, A W; Mann, S; Tamborrini, M; Pluschke, G; Robinson, J A (2011). Engineered synthetic virus-like particles and their use in vaccine delivery. ChemBioChem, 12(1):100-109.
    • Davidson, A; Patora-Komisarska, K; Robinson, J A; Varani, G (2011). Essential structural requirements for specific recognition of HIV TAR RNA by peptide mimetics of Tat protein. Nucleic Acids Research, 39(1):248-256.
    • VanderMeijden, B; Robinson, J A (2011). Synthesis and application of photoproline - a photoactivatable derivative of proline. Arkivoc, 2011(vi):130-136.
    • Moehle, K; Freund, A; Kubli, E; Robinson, J A (2011). NMR studies of the solution conformation of the sex peptide from Drosophila melanogaster. FEBS Letters, 585(8):1197-1202.
    • Robinson, J A (2011). Protein epitope mimetics as anti-infectives. Current Opinion in Chemical Biology, 15(3):379-386.

  • 2010

    • Srinivas, N; Jetter, P; Ueberbacher, B J; Werneburg, M; Zerbe, K; Steinmann, J; Van der Meijden, B; Bernardini, F; Lederer, A; Dias, R L A; Misson, P E; Henze, H; Zumbrunn, J; Gombert, F O; Obrecht, D; Hunziker, P; Schauer, S; Ziegler, U; Käch, A; Eberl, L; Riedel, K; DeMarco, S J; Robinson, J A (2010). Peptidomimetic antibiotics target outer membrane biogenesis in Pseudomonas aeruginosa. Science, 327(5968):1010-1013.
    • Geib, N; Weber, T; Wörtz, T; Zerbe, K; Wohlleben, W; Robinson, J A (2010). Genome mining in amycolatopsis balhimycina for ferredoxins capable of supporting cytochrome P450 enzymes involved in glycopeptide antibiotic biosynthesis. FEMS Microbiology Letters, 306(1):45-53.
    • Perriman, A W; Williams, D S; Jackson, A J; Grillo, I; Koomullil, J M; Ghasparian, A; Robinson, J A; Mann, S (2010). Synthetic virus-like particles and hybrid constructs based on lipopeptide self-assembly. Small, 6(11):1191-1196.
    • Mädler, S; Seitz, M; Robinson, J A; Zenobi, R (2010). Does chemical cross-linking with NHS esters reflect the chemical equilibrium of protein-protein noncovalent interactions in solution?. Journal of the American Society for Mass Spectrometry, 21(10):1775-1783.
    • Seitz, M; Rusert, P; Moehle, K; Trkola, A; Robinson, J A (2010). Peptidomimetic inhibitors targeting the CCR5-binding site on the human immunodeficiency virus Type-1 gp120 glycoprotein complexed to CD4. Chemical Communications, 46(41):7754-7756.

  • 2009

    • Tamborrini, M; Mueller, M S; Stoffel, S A; Westerfeld, N; Vogel, D; Boato, F; Zurbriggen, R; Robinson, J A; Pluschke, G (2009). Design and pre-clinical profiling of a Plasmodium falciparum MSP-3 derived component for a multi-valent virosomal malaria vaccine. Malaria Journal, 8:314.
    • Davidson, A; Leeper, T C; Athanassiou, Z; Patora-Komisarska, K; Karn, J; Robinson, J A; Varani, G (2009). Simultaneous recognition of HIV-1 TAR RNA bulge and loop sequences by cyclic peptide mimics of Tat protein. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 106(29):11931-11936.
    • Grässlin, A; Amoreira, C; Baldridge, K K; Robinson, J A (2009). Thermodynamic and computational studies on the binding of p53-derived peptides and peptidomimetic inhibitors to HDM2. ChemBioChem, 10(8):1360-1368.
    • Robinson, J A (2009). Design of protein-protein interaction inhibitors based on protein epitope mimetics. ChemBioChem, 10(6):971-973.
    • Touboul, D; Maillard, L; Grässlin, A; Moumne, R; Seitz, M; Robinson, J A; Zenobi, R (2009). How to Deal with Weak Interactions in Noncovalent Complexes Analyzed by Electrospray Mass Spectrometry: Cyclopeptidic Inhibitors of the Nuclear Receptor Coactivator 1-STAT6. Journal of the American Society for Mass Spectrometry, 20(2):303-311.
    • Obrecht, D; Robinson, J A; Bernardini, F; Bisang, C; DeMarco, S J; Moehle, K; Gombert, F O (2009). Recent progress in the discovery of macrocyclic compounds as potential anti-infective therapeutics. Current Medicinal Chemistry, 16(1):42-65.

Pagination